市場調查報告書
商品編碼
1558263
到 2030 年單位劑量包裝市場預測:按產品、材料、分銷管道、應用、最終用戶和地區進行的全球分析Unit Dose Packaging Market Forecasts to 2030 - Global Analysis By Product (Blister Packs, Vials, Ampoules, Pre-filled Syringes, Pouches, Bottles and Other Products), Material, Distribution Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球單位劑量包裝市場規模為 305.2 億美元,預計到 2030 年將達到 452.9 億美元,預測期內複合年成長率為 9.5%。
單位劑量包裝是一種包裝藥品和其他產品的方法,其中每個劑量單獨包裝在一次性容器中。此系統可確保準確劑量,最大限度地降低污染風險,並透過防止誤用和意外用藥過量來提高病患安全。單位劑量包裝通常用於醫療保健環境,可簡化劑量並有助於庫存管理。每個單位劑量都經過預先測量和標記,使醫療保健提供者更容易追蹤藥物並確保遵守規定的治療。
印度品牌股權基金會(IBEF)2021年6月發布的報告顯示,印度製藥業佔全球各類疫苗需求的50%以上,占美國非專利需求的40%,佔英國整體藥品供應量的25%以上。
慢性病增加
慢性疾病通常需要長期一致的治療方法,而準確的劑量對於有效的治療至關重要。單位劑量包裝可確保患者每次都收到正確的劑量,從而降低用藥錯誤的風險並提高用藥依從性。這種包裝形式對於那些難以應對複雜用藥方案的老年人和慢性疾病患者特別有益,提高了患者的安全性和便利性。隨著慢性病變得越來越普遍,對單位劑量包裝的需求也不斷增加。
監管障礙
由於不同地區和國家對安全性、有效性和品管的嚴格要求不同,單位劑量包裝面臨監管障礙。這些法規要求嚴格的測試、記錄和遵守標準,使得開發和核准過程複雜且成本高昂。這些監管挑戰可能會延遲產品發布、增加製造成本並限制新參與企業的市場准入。因此,這些因素可能會限制技術創新的步伐並增加製造商的財務負擔,從而阻礙市場成長。
醫療保健設施的成長
醫院、診所和長期照護中心等醫療保健設施的激增增加了對高效、安全的藥品分配系統的需求。隨著更多設施的建立,對準確、隨時給藥的劑量的需求增加,推動了單位劑量包裝的採用。這種包裝方法對於擴大醫療保健環境以支持簡化操作、減少用藥錯誤和提高患者安全至關重要。
製造成本高
由於單一容器設計和製造、精確劑量機制和品管措施的複雜性,單位劑量包裝的製造成本更高。對特殊材料和技術(例如阻隔膜和防竊啟密封件)的需求也導致成本增加。這些成本增加可能會影響整體盈利和定價,使單位劑量包裝與散裝替代品相比吸引力下降。因此,不斷上升的製造成本可能會限制市場採用,特別是在成本敏感地區,並阻礙單位劑量包裝市場的成長。
COVID-19 的影響
由於單位劑量包裝在提高安全性和降低交叉污染風險方面的作用,COVID-19 大流行增加了對單位劑量包裝的需求。對準確劑量和感染控制的需求促使醫療保健機構更廣泛地採用單位劑量系統。然而,供應鏈中斷和原料成本上漲成為問題。此次疫情也加速了包裝自動化和數位解決方案的發展趨勢,以管理大量藥品並確保高效配送。
預填充式注射器細分市場預計將成為預測期內最大的細分市場
預計預填充式注射器細分市場在預測期內將是最大的。單位劑量包裝的預填充式注射器為給藥提供了方便、準確的解決方案。每個注射器都預先計量了單劑量的藥物,減少了劑量錯誤和污染的風險。這種包裝方法透過簡化管理流程和提高病人安全來提高醫療機構的效率。它對於生物製劑、疫苗和慢性病藥物特別有用,可確保醫療保健專業人員和患者的劑量準確且易於使用。
生物製品產業預計在預測期內複合年成長率最高。
生物製品領域預計在預測期內複合年成長率最高。 Biologic 的單位劑量包裝可確保複雜藥物的準確和安全劑量。這種包裝方法為每個劑量提供一次性容器,最大限度地減少污染和劑量錯誤的風險。它對於生物製劑特別有用,其脆弱的性質通常需要嚴格的處理和精確的劑量。透過簡化準備工作並降低交叉污染的風險,單位劑量包裝可提高病患的安全性和依從性,同時提高醫療機構的效率。
在亞太地區,單位劑量包裝市場正在迅速擴大,由於醫療基礎設施的不斷增加、對患者安全的日益關注以及慢性病的流行,預計將佔據最大的市場佔有率。該地區的製藥業多元化,對高效、準確的給藥系統的需求不斷成長。先進封裝技術的創新和嚴格的法規進一步支持市場成長。此外,醫院、診所和療養院的擴張正在推動對單位劑量解決方案的需求,以加強該地區各國的藥物管理和患者照護。
在北美,由於對患者安全、監管要求和技術進步的強烈關注,單位劑量包裝市場正在經歷顯著成長。該地區強大的醫療基礎設施和慢性病的高盛行率推動了對準確、高效的藥物管理系統的需求。包裝技術的創新和對減少用藥錯誤的日益關注也推動了市場的擴張。此外,醫療機構數量的增加、庫存管理的改善和用藥依從性也促進了北美市場的成長。
According to Stratistics MRC, the Global Unit Dose Packaging Market is accounted for $30.52 billion in 2024 and is expected to reach $45.29 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Unit dose packaging refers to a method of packaging pharmaceuticals or other products where each dose is individually packaged in a single-use container. This system ensures accurate dosing, minimizes the risk of contamination, and enhances patient safety by preventing misuse or accidental overdose. Typically used in healthcare settings, unit dose packaging simplifies administration and helps with inventory management. Each unit dose is pre-measured and labeled, making it easier for healthcare providers to track medication and ensure compliance with prescribed treatments.
According to the report published in June 2021 by the India Brand Equity Foundation (IBEF), the Indian pharmaceutical sector supplies more than 50% of the global demand for various vaccines, 40% of the generic demand in the U.S., and over 25% of total medicines in the U.K.
Rising chronic diseases
Chronic conditions often require long-term, consistent treatment regimens, making accurate dosing essential for effective management. Unit dose packaging ensures that patients receive the correct dose every time, reducing the risk of medication errors and improving adherence. This packaging format is particularly beneficial for elderly and chronically ill patients, who may struggle with complex medication schedules, thus enhancing their safety and convenience. As chronic diseases become more common, the demand for unit dose packaging continues to grow.
Regulatory hurdles
Unit dose packaging faces regulatory hurdles due to stringent requirements for safety, efficacy, and quality control, which vary by region and country. These regulations mandate rigorous testing, documentation, and compliance with standards, making the development and approval process complex and costly. Such regulatory challenges can delay product launches, increase production costs, and restrict market entry for new players. Consequently, these factors can hamper market growth by limiting the pace of innovation and increasing the financial burden on manufacturers.
Growth in healthcare facilities
The growth in healthcare facilities, including hospitals, clinics, and long-term care centers, increases the demand for efficient and safe medication distribution systems. As more facilities are established, the need for precise, ready-to-administer medication doses rises, driving the adoption of unit dose packaging. This packaging method supports streamlined operations, reduces medication errors, and enhances patient safety, making it essential in expanding healthcare settings.
High production costs
Unit dose packaging incurs high production costs due to the complexity of designing and manufacturing individual containers, precise dosing mechanisms, and quality control measures. The specialized materials and technologies required, such as barrier films and tamper-evident seals, contribute to increased expenses. These higher costs can impact overall profitability and pricing, making unit dose packaging less attractive compared to bulk alternatives. Consequently, the elevated production costs can limit market adoption, especially in cost-sensitive regions, and hinder the growth of the unit dose packaging market.
Covid-19 Impact
The covid-19 pandemic heightened the demand for unit dose packaging due to its role in improving safety and reducing cross-contamination risks. The need for precise medication dosing and infection control drove healthcare facilities to adopt unit dose systems more widely. However, supply chain disruptions and increased costs of raw materials posed challenges. The pandemic also accelerated trends towards automation and digital solutions in packaging to manage high volumes and ensure efficient distribution of medications.
The pre-filled syringes segment is expected to be the largest during the forecast period
The pre-filled syringes segment is estimated to be the largest during the forecast period. Pre-filled syringes in unit dose packaging offer a convenient and precise solution for medication administration. Each syringe is pre-measured with a single dose of medication, reducing the risk of dosing errors and contamination. This packaging method improves efficiency in healthcare settings by streamlining the administration process and enhancing patient safety. It is particularly valuable for biologics, vaccines, and chronic condition treatments, ensuring accurate dosing and ease of use for both healthcare providers and patients.
The biologics segment is expected to have the highest CAGR during the forecast period
The biologics segment is anticipated to witness the highest CAGR growth during the forecast period. Unit dose packaging in biologics ensures precise and safe administration of complex medications. This packaging method provides single-use containers for each dose, minimizing contamination risks and dosing errors. It is particularly beneficial for biologics, which often require stringent handling and accurate dosing due to their sensitive nature. By streamlining preparation and reducing the risk of cross-contamination, unit dose packaging enhances patient safety and adherence while improving efficiency in healthcare settings.
In the Asia-Pacific region, the unit dose packaging market is expanding rapidly and is anticipated to register the largest market share due to increasing healthcare infrastructure, a rising focus on patient safety, and growing chronic disease prevalence. The region's diverse pharmaceutical industry drives demand for efficient and precise medication delivery systems. Innovations in packaging technology and regulatory advancements further support market growth. Additionally, the expansion of hospitals, clinics, and long-term care facilities boosts the need for unit dose solutions, enhancing medication management and patient care across various countries in the region.
In North America, the unit dose packaging market is experiencing significant growth driven by a strong focus on patient safety, regulatory requirements, and technological advancements. The region's robust healthcare infrastructure and high prevalence of chronic diseases increase demand for precise and efficient medication management systems. Innovations in packaging technology and a growing emphasis on reducing medication errors support market expansion. Additionally, the rise in healthcare facilities and the push for improved inventory management and medication adherence further contribute to the market's growth in North America.
Key players in the market
Some of the key players profiled in the Unit Dose Packaging Market include BD (Becton, Dickinson and Company), Gerresheimer AG, West Pharmaceutical Services Inc., Nemera, MediSafe, Omnicare Inc., AccuStar Packaging, Schaefer Technologies Inc., Pharmapack, Paragon Healthcare, Lonza, Trellis Pharma, Systech International, Vetter Pharma-Fertigung GmbH & Co. KG, Uhlmann Pac-Systeme GmbH & Co. KG and Jones Healthcare.
In September 2022, BD (Becton, Dickinson and Company) introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity. The new BD EffivaxTM Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.
In August 2022, Jones Healthcare Launched Sustainable FlexRx(TM) one blister pack, designed for automation. The new unit-dose adherence package is ideal for retail, specialty and long-term care pharmacies using centralized fulfillment or automation in-house. This bioplastic is manufactured from renewable resources, is free of any chemicals of concern, and is also readily recyclable across most households in North America.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.